Recombinant Human Fibronectin Fragment 3 Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 3938-FN
Key Product Details
Product Specifications
Source
Glu1266-Pro1908 (Met1874Thr), with a C-terminal 6-His tag
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
When 5 x 104 cells/well are added to Recombinant Human Fibronectin Fragment 3/amino acids
1266-1908 coated plates (1 µg/mL with 100 µL/well), approximately 50‑75% will adhere after 30-60 minutes at 37 °C.
Optimal concentration depends on cell type as well as the application or research objective.
Formulation, Preparation and Storage
3938-FN
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS and Tween® 20. |
Reconstitution |
Reconstitute at 100 μg/mL in sterile PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Fibronectin
Fibronectin (FN) is a large modular glycoprotein that is found as a polymeric fibrillar network in the extracellular matrix (ECM) and as soluble disulfide-linked dimeric protomers in plasma and other body fluids (1, 2). The protein subunit is made up of three types of homologous structural motifs termed FN type I, type II, and type III repeats (3 - 5). Alternative splicing generates multiple isoforms of Fibronectin which may have insertions of extra type III domains (EDA and EDB) or alteration of the type III connecting segment (IIICS) (5). Fibronectin is a ligand for many molecules including fibrin, heparin, chondroitin sulfate, collagen/gelatin, and integrins. It is involved in multiple cellular processes such as cell adhesion/migration, blood clotting, morphogenesis, tissue repair, and cell signaling. Fibronectin functions are mediated by the insoluble polymeric fibrils in the ECM. Conversion of soluble Fibronectin to Fibronectin fibrils in the ECM is initiated by binding to cell surface integrins, resulting in exposure of cryptic epitopes necessary for polymerization (1). FN1.3 includes the EDB plus type III domains #8 - 13 and the initial region of domain 14. These domains facilitate association with heparin, myocilin, ApoA, and integrins alpha5 beta1 and alphaV beta3 (6 - 10). The tilt angle between type III domains #9 and #10 (which contains an RGD motif) determines the affinity of interaction with these integrins, suggesting how structural differences between fibrillar and soluble Fibronectin may influence their function (10). Within FN1.3, human Fibronectin shares 97% and 92% aa sequence identity with mouse and rat Fibronectin, respectively.
References
- Mao, Y. and J.E. Schwarzbauer (2005) Matrix Biol. 24:389.
- Potts, J.R. and I.D. Campbell (1996) Matrix Biol. 15:313.
- Bernard, M.P. et al. (1985) Biochemistry 24:2698.
- Kornblihtt, A.R. et al. (1983) Proc. Natl. Acad. Sci. USA 80:3218.
- Kornblihtt, A.R. et al. (1985) EMBO J. 4:1755.
- Peters, D.M. et al. (2005) Exp. Cell Res. 303:218.
- Edelstein, C. et al. (2005) J. Lipid Res. 46:2673.
- Pytela, R. et al. (1985) Cell 40:191.
- Wayner, E.A. et al. (1989) J. Cell Biol. 109:1321.
- Altroff, H. et al. (2004) J. Biol. Chem. 279:55995.
Alternate Names
Gene Symbol
UniProt
Additional Fibronectin Products
Product Documents for Recombinant Human Fibronectin Fragment 3 Protein, CF
Product Specific Notices for Recombinant Human Fibronectin Fragment 3 Protein, CF
For research use only